MKO Troche Interactions
There are 810 drugs known to interact with MKO Troche (ketamine / midazolam / ondansetron), along with 16 disease interactions, and 4 alcohol/food interactions. Of the total drug interactions, 330 are major, 451 are moderate, and 29 are minor.
- View all 810 medications that may interact with MKO Troche
- View MKO Troche alcohol/food interactions (4)
- View MKO Troche disease interactions (16)
Most frequently checked interactions
View interaction reports for MKO Troche (ketamine / midazolam / ondansetron) and the medicines listed below.
- biotin
- Centrum (multivitamin with minerals)
- cetirizine
- clonazepam
- Cymbalta (duloxetine)
- Deplin (l-methylfolate)
- folic acid
- glycopyrrolate
- Lactaid (lactase)
- Linzess (linaclotide)
- metformin
- naltrexone
- Nexium (esomeprazole)
- RepHresh (emollients topical)
- Seasonique (ethinyl estradiol / levonorgestrel)
- Seroquel (quetiapine)
- Synthroid (levothyroxine)
- Thorazine (chlorpromazine)
- Unisom SleepTabs (doxylamine)
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
- Wellbutrin (bupropion)
MKO Troche alcohol/food interactions
There are 4 alcohol/food interactions with MKO Troche (ketamine / midazolam / ondansetron).
MKO Troche disease interactions
There are 16 disease interactions with MKO Troche (ketamine / midazolam / ondansetron) which include:
- acute alcohol intoxication
- closed-angle glaucoma
- respiratory depression
- seizures
- prolonged hypotension
- hypertension
- prematurity
- CNS depression/electrolyte disturbances
- congestive heart failure
- renal/liver disease
- QT interval prolongation
- depression
- obesity
- paradoxical reactions
- alcoholism
- liver disease
Report options
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.